Rumela Chakrabarti

9PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - lipidsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2026
KRT17 promotes triple negative breast cancer through activation of Wnt signaling and γδ T-cells recruitment.

Chermakani Panneer Selvam, Gatha Thacker, Ukjin Kim

|Oct 14, 2025
MDSCs in Breast Cancer: Metastasis, Lipid Metabolism, and Therapeutics.

Ukjin Kim, Rumela Chakrabarti

|Jul 05, 2023
Challenges of Using IFNγ in Clinical Settings.

Snahlata Singh, Rumela Chakrabarti

|Aug 25, 2022
Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer.

Ajeya Nandi, Rahul Debnath, Anupma Nayak

|Aug 05, 2021
Author Correction: Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Snahlata Singh, Sushil Kumar, Ratnesh Kumar Srivastava

|Jan 30, 2021
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer.

Christoforos Thomas, Ilias V Karagounis, Ratnesh K Srivastava

Pageof 2

Frequent Collaborators

2 joint publications

Rizwan Saffie

2 joint publications

Satrajit Sinha

2 joint publications

Luca Busino

2 joint publications

Serge Y Fuchs